Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Nelson L. Michael"'
Autor:
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B. Morrison, Rajeshwer S. Sankhala, Wei-Hung Chen, William C. Chang, Jessica S. Bolton, Gary R. Matyas, Nelson L. Michael, M. Gordon Joyce, Kayvon Modjarrad, Jeffrey R. Currier, Elke Bergmann-Leitner, Allison M. W. Malloy, Mangala Rao
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-18 (2021)
NPJ Vaccines
NPJ Vaccines
The emergence of variants of concern, some with reduced susceptibility to COVID-19 vaccines underscores consideration for the understanding of vaccine design that optimizes induction of effective cellular and humoral immune responses. We assessed a S
Autor:
Peter D. Kwong, Misook Choe, Bonnie M. Slike, M. Gordon Joyce, Samantha M. Townsley, Elizabeth J. Martinez, Tongqing Zhou, Lindsay Wieczorek, Morgane Rolland, Kayvon Modjarrad, Dominic Paquin-Proulx, Vincent Dussupt, Weam I. Zaky, Nelson L. Michael, Magdalena Rutkowska, Isabella Swafford, Benjamin J. Doranz, Shelly J. Krebs, Theodora Hatziioannou, Gregory D. Gromowski, Ningbo Jian, Caroline E. Peterson, Phyllis A. Rees, Clayton Smith, Michelle Zemil, Paul D. Bieniasz, Kerri G. Lal, Victoria R. Polonis, I-Ting Teng, Gina Donofrio, William W. Reiley, Wei-Hung Chen, Christopher N. Selverian, Rajeshwer S. Sankhala, Jeffrey R. Currier, Aslaa Ahmed, Letzibeth Mendez-Rivera, Ursula Tran, Nathaniel D. Jackson, Agnes Hajduczki, Paul V. Thomas, Sarah R. Tritsch, William C. Chang, Fabian Schmidt, Edgar Davidson, Christopher N. Mores
Publikováno v:
Nature Immunology
Prevention of viral escape and increased coverage against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern require therapeutic monoclonal antibodies (mAbs) targeting multiple sites of vulnerability on the coronavirus s
Autor:
Sandrine Soman, Shelly J. Krebs, Diane L. Bolton, Gregory D. Gromowski, Ines Lakhal-Naouar, Swagata Kar, Michelle Zemil, Linda L. Jagodzinski, Amy R. Henry, Robert A. Seder, Lindsay Wieczorek, Hannah Grove, Dominic Paquin-Proulx, Adrienne Winn, Daniel C. Douek, Holly R. Hack, Caitlin Kuklis, Kamil Radzyminski, Rafael De La Barrera, Matthew Gagne, Caroline E. Peterson, James F. Wood, Heather Hernandez, Alexander R. A. Anderson, Xiankun Zeng, Stasya Zarling, Wei-Hung Chen, Mark G. Lewis, Rajeshwer S. Sankhala, Prakriti Mudvari, Andrew Pekosz, Victoria R. Polonis, Maciel Porto, Mangala Rao, Paul V. Thomas, Eli Boritz, M. Gordon Joyce, Sheila A. Peel, Elham Bayat Mokhtari, Kathryn McGuckin Wuertz, Nelson L. Michael, Sharon P. Daye, Akshaya Ganesh, Agnes Hajduczki, Gary R. Matyas, Jeffrey W. Froude, Vincent Dussupt, Erica K. Barkei, Kayvon Modjarrad, Jeffrey R. Currier, Sandhya Vasan, Janice Darden, Isabella Swafford, Elizabeth J. Martinez, Mehul S. Suthar, Ming Dong
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
NPJ Vaccines
NPJ Vaccines
The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a SARS-CoV-2 spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferre
Publikováno v:
Lancet HIV
Summary The advanced-phase HIV prevention vaccine trials done in South Africa (HVTN 702) and in Thailand (RV144), which both investigated canarypox vectors and adjuvanted gp120 proteins, gave rise to different results. The South African trial did not
Autor:
Jessica L Ansel, Dan H. Barouch, Kayvon Modjarrad, Katherine E. Yanosick, Lauren Peter, Edward T. Moseley, Rafael De La Barrera, Tatenda Makoni, Michael S. Seaman, Peter Dawson, Rachel Fogel, Joseph P. Nkolola, Kathryn E. Stephenson, Stephen R. Walsh, Andrew J. Hale, Diane G. Kanjilal, Kate Jaegle, Nelson L. Michael, Stephen J. Thomas, Connor Bradshaw, Abishek Chandrashekar, Jason Thompson, Kenneth H. Eckels, Erica N. Borducchi, Anna Tyler, Chen S. Tan
Publikováno v:
Lancet Infect Dis
Summary Background The development of an effective vaccine against Zika virus remains a public health priority. A Zika purified inactivated virus (ZPIV) vaccine candidate has been shown to protect animals against Zika virus challenge and to be well t
Autor:
Afoke Kokogho, Trevor A Crowell, Sylvia Adebajo, Rebecca G. Nowak, Stefan Baral, Nelson L. Michael, Merlin L. Robb, Casey Storme, Julie A Ake, Senate Amusu, Veronica Tonwe, Olumide Makanjuola, Manhattan E Charurat
Publikováno v:
Archives of sexual behavior
Disclosure of same-sex sexual practices by men who have sex with men (MSM) and transgender women (TGW) may facilitate appropriate healthcare engagement, including risk assessment for HIV and other sexually transmitted infections (STIs), and negotiati
Autor:
Megan C. Wise, Kristopher Paolino, Deborah Kane, Claude Lamarre, Faraz I. Zaidi, Paul T. Scott, Ajay P. Parikh, Stephen J. Thomas, Young K. Park, Scott White, Sagar B. Kudchodkar, David B. Weiner, Amy R. Castellano, Elizabeth K. Duperret, Trina Racine, Myoung Don Oh, Merlin L. Robb, Hyeree Choi, Kristin Mills, Mark L. Bagarazzi, Jeanine M. May, Joel N. Maslow, Janice Darden, Emma L. Reuschel, Moonsup Jeong, Celine Remigio, Kayvon Modjarrad, Karuppiah Muthumani, Ami Patel, Kevin Kim, Nelson L. Michael, Jean D. Boyer, Hyo Jin Lee, Gary P. Kobinger, Christine C. Roberts
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Middle East respiratory syndrome (MERS) coronavirus causes a highly fatal lower-respiratory tract infection. There are as yet no licensed MERS vaccines or therapeutics. This study (WRAIR-2274) assessed the safety, tolerability, and
Autor:
Chris Beyrer, Myron S. Cohen, Lawrence Corey, Nelson L. Michael, Trevor Bedford, Morgane Rolland
Publikováno v:
N Engl J Med
SARS-CoV-2 and Immunosuppression In this article, the authors discuss the challenges of SARS-CoV-2 infection in patients with a weakened immune system, including the potential implications regardin...
Autor:
Kathryn McGuckin Wuertz, Matthew Gagne, Sharon P. Daye, Gary R. Matyas, Erica K. Barkei, Swagata Kar, Rafael De La Barrera, Caroline E. Peterson, Elyham Bayat Mokhtari, Michelle Zemil, Linda L. Jagodzinski, Elizabeth J. Martinez, Sandrine Soman, Mehul S. Suthar, Wei-Hung Chen, M. Gordon Joyce, Sheila A. Peel, Dominic Paquin-Proulx, Heather Hernandez, Rajeshwer S. Sankhala, Sandhya Vasan, Stasya Zarling, Caitlin Kuklis, Janice Darden, Andrew Pekosz, Diane L. Bolton, Ming Dong, Mark G. Lewis, Xiankun Zeng, Paul V. Thomas, Victoria R. Polonis, James F. Wood, Marciel Porto, Prakriti Mudvari, Ines Elakhal Naouar, Daniel C. Douek, Shelly J. Krebs, Holly R. Hack, Mangala Rao, Eli Boritz, Gregory D. Gromowski, Kamil Radzyminski, Robert A. Seder, Alexander R. A. Anderson, Akshaya Ganesh, Hannah Grove, Isabella Swafford, Amy R. Henry, Adrienne Winn, Agnes Hajduczki, Nelson L. Michael, Kayvon Modjarrad, Jeffrey W. Froude, Lindsey Wieczorek, Vincent Dussupt, Jeffrey R. Currier
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferred protectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f22541b3a4b216dde47acf2f8f3ef8
https://doi.org/10.1101/2021.06.16.448525
https://doi.org/10.1101/2021.06.16.448525
Autor:
Shuying S. Li, Andrew Hickey, Shida Shangguan, Philip K. Ehrenberg, Aviva Geretz, Lauryn Butler, Gautam Kundu, Richard Apps, Matthew Creegan, Robert J. Clifford, Suteeraporn Pinyakorn, Leigh Anne Eller, Pikunchai Luechai, Peter B. Gilbert, Timothy H. Holtz, Anupong Chitwarakorn, Carlo Sacdalan, Eugène Kroon, Nittaya Phanuphak, Mark de Souza, Jintanat Ananworanich, Robert J. O'Connell, Merlin L. Robb, Nelson L. Michael, Sandhya Vasan, Rasmi Thomas
Publikováno v:
Cell Host Microbe
Cell host & microbe, 30(8), 1173-1185.E8. Cell Press
Cell host & microbe, 30(8), 1173-1185.E8. Cell Press
Human leukocyte antigen (HLA) alleles have been linked to HIV disease progression and attributed to differences in cytotoxic T lymphocyte (CTL) epitope representation. These findings are largely based on treatment-naive individuals of European and Af